GLANDNSEGland Pharma LimitedMediumNeutral
Announced Thu, 14 May · 18:24 IST

Gland Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

Management Changes View source PDF

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.6%1-day move
₹1895.00
prior close
₹1910.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.5-1.6-0.8+13.6+18.0+16.9+23.4+22.7+21.5+18.5+16.5+30.0
Up moveDown movePending
AI summary

Gland Pharma Limited's shareholders have approved the reappointment of Ms. Naina Lal Kidwai as an Independent Director through a postal ballot via remote e-voting. The special resolution was passed with overwhelming support — out of ~14.94 crore votes cast, 94.18% were in favour (14.07 crore votes) while 5.82% were against (86.97 lakh votes). Promoter and promoter group voted unanimously in favour (100%), while public institutions approved at 86.42%. The company also sought approval to pay her commission on profits as remuneration.

Likely market impact

The reappointment of a senior independent director like Naina Lal Kidwai is a routine governance step and signals board stability. The near-unanimous approval from all shareholder categories is positive for the company's governance standing.